News Announcement

Camson Bio Technologies: Outcome of Board Meeting

Further to our letter dated 29th August 2017, the Board of the Directors at its meeting held today, which commenced at 4.30 P.M. and concluded at 5.15 P.M., inter-alia considered and approved the unaudited Financial results of the Company for the 1st quarter ended 30th June 2017. These financial statements of have been prepared in accordance with Ind AS and adopted by the Company for the first time.
The Limited review report issued by YCRJ & Associates is also attached herewith.

Please treat this as compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015
This is for your information and record.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.